肠道代谢物预测抑郁症和焦虑症患者的耐治疗性
Juntaro Matsuzaki1, Shunya Kurokawa2,3, Chiaki Iwamoto4
1Division of Pharmacotherapeutics, Keio University Faculty of Pharmacy, 1-5-30 Shibakoen, Minato-ku, Tokyo, 105-8512, Japan. juntaro.matsuzaki@keio.jp.
便N-ε-乙利氨酸的低基线水平可以预测耐治疗抑郁症和焦虑症. 这种与肠道微生物群相关的代谢物显示出作为治疗结果的生物标志物的潜力.
科学领域:
- 神经科学是一个神经科学.
- 微生物组研究 微生物组研究
- 代谢学 代谢学 代谢学
背景情况:
- 对肠道微生物群对神经精神疾病的影响越来越感兴趣.
- 关于肠道代谢物和抑郁症和焦虑症治疗耐药性的数据有限.
研究的目的:
- 在患有抑郁和焦虑障碍的患者中研究肠道代谢物.
- 探索这些代谢物在治疗耐药性中的作用.
主要方法:
- 对34名患有抑郁和焦虑症的参与者的便代谢物和微生物组的分析.
- 在处理过程中,在三个时间点收集便样本.
- 倾向性得分对应对分析的响应者与非响应者,在残余样本中验证.
主要成果:
- N-ε-乙氨酸被确定为关键代谢物;在治疗反应者中观察到较低的基线水平 (AUC=0.86).
- 便中的N-ε-乙氨酸水平与Odoribacter的丰富性有负面关联.
- 增加N-ε-乙氨酸水平与治疗期间症状改善相关.
结论:
- 在治疗前的便中,N-ε-乙氨酸可以作为治疗不耐药抑郁症和焦虑症的预测生物标志物.
- 臭菌可能会影响肠道L-氨酸恒温.
- 在抑郁和焦虑的背景下,L-lysine代谢需要进一步关注.
更多相关视频
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
07:49Intracerebroventricular Delivery of Gut-Derived Microbial Metabolites in Freely Moving Mice
Published on: June 2, 2022
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Antidepressant Drugs: Overview
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Drugs for Treatment of Constipation-Predominant IBS
